Sysmex (6869.T) Financial Analysis & Valuation | Quarter Chart
Sysmex (6869.T)
6869.TPrice: $8.77
Fair Value: 🔒
🔒score
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in la... more
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reag... more
Description
Shares
| Market Cap | $5.40B | Exchange | JPX |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | JP | CEO | Hisashi Ietsugu |
| IPO Date | 2001-01-01 | CAGR | 0.09% |
| Employees | 10,042 | Website | www.sysmex.co.jp |
| Div. Yield | 2.68% | Payout Ratio | 0.63% |
| Buy Back Yield | 0.37% | Total Yield | 3.05% |
6869.T chart loading...
Fundamentals
Technicals
| Enterprise Value | $834.62B | P/E Ratio | 24.54 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 1.74 | P/B Ratio | 1.74 |
| P/CF Ratio | 11.92 | P/FCF Ratio | 21.34 |
| EPS | $0.36 | EPS Growth 1Y | -33.88% |
| EPS Growth 3Y | -21.97% | EPS Growth 5Y | 7.77% |
| Revenue Growth 1Y | -1.7% | Gross Margin | 0.51% |
| Operating Margin | 0.12% | Profit Margin | 0.07% |
| ROE | 0.07% | ROA | 0.05% |
| ROCE | 0.11% | Current Ratio | 3.26 |
| Quick Ratio | 2.46 | Cash Ratio | 0.71 |
| Debt/Equity | 0.14 | Interest Coverage | 14.26 |
| Altman Z Score | 4.85 | Piotroski Score | 7 |